Merck profit beats forecast on impressive sales

Reuters

Merck

The No. 2 U.S. drugmaker said on Friday it earned $1.69 billion, or 55 cents per share, in the third quarter. That compared with $342 million, or 11 cents per share, in the year-ago period, when the company took several big charges.

Continue Reading Below

Excluding special items, Merck earned 94 cents per share. Analysts on average expected 91 cents per share, according to Thomson Reuters I/B/E/S.

Global revenue rose 8 percent to $12.02 billion, topping Wall Street expectations of $11.61 billion.

(Reporting by Ransdell Pierson; Editing by Derek Caney)

What do you think?

Click the button below to comment on this article.